# LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

> **NCT00214630** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 825 (actual)

## Conditions studied

- Acute Coronary Syndromes

## Interventions

- **DRUG:** rosuvastatin calcium
- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00214630
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 825 (ACTUAL)
- **Last updated:** 2010-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214630, "LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00214630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*